PIVOT3
13.10.2015 08:01:44 CEST | Business Wire | Press release
Pivot3 , a pioneer and innovator in the development of hyper-converged infrastructure (HCI), today announced it will bring its HCI technology to VMware vSphere® 6.
VMware vSphere 6 is the industry-leading virtualization platform for the hybrid cloud and the foundation for the software-defined data center. VMware vSphere 6 provides customers with a highly available, resilient, on-demand cloud infrastructure to run, protect and manage any application.
The newest edition of Pivot3’s patented vSTAC OS software, vSTAC OS 7 which uses patented Scalar Erasure Coding technology, is now built on a foundation of VMware vSphere 6 which enables GPU virtualization, higher fault tolerance and greater availability on Pivot3’s HCI platforms.
The upcoming release of the vSTAC OS Management Client Integration Plug-In integrates with the VMware vSphere 6 Web Client interface to enable users to manage their entire Pivot3 hyper-converged array of nodes which scales to petabytes of storage and millions of Input/Output Operations Per Second (IOPS) – all from a central console.
Pivot3’s global hyper-converged infrastructure solution helps enterprises achieve low total cost of ownership by providing combined virtualized shared storage and compute power on the same platform, eliminating the need for separate physical storage area networks (SANs) and servers. The streamlined vSTAC OS 7 dashboard provides VMware server administrators and application owners with an easy-to-manage status view and control console for the combined Pivot3 virtual SAN and compute environment.
“Pivot3’s HCI provides the performance and high-availability of shared storage without the need for expensive external storage arrays,” said Ron Nash, CEO of Pivot3. “With Pivot3 global HCI, growing enterprises and organizations with multiple locations, such as remote or branch offices (ROBOs), can deploy critical applications and associated data onsite so that they are available at all times without needing access to company-wide networks.”
Pivot3 also supports End User Computing (EUC) licensing of VMware Horizon® 6 for desktop virtualization. VMware Horizon provides end-users access to all of their virtual desktops, applications and online services through a single workspace.
“Pivot3’s HCI with VMware vSphere 6 provides enterprise customers with a scale-out, distributed storage architecture,” said Howard Hall, senior director, Global Technology Partner Organization, VMware. “Pivot3's efficient, high-performance infrastructure combining storage and compute capabilities with VMware vSphere can accelerate time to value for organizations, which means that they can now deploy their solution much faster with less specialized expertise, all at a lower cost. The result is that customers can benefit from increased CPU power to more efficiently run advanced VMware vSphere 6 features.”
Pivot3, with its efficient and scalable HCI, has been a VMware supporter since 2008. The immediate support for VMware vSphere 6 builds on Pivot3’s longstanding partnership with VMware, which includes support for VMware Horizon and VMware Mirage™, as well as 100 percent reliance on VMware vSphere.
Pivot3 has 1,600 customers around the world. Enterprise customers who buy Pivot3 HCI also buy Enterprise and Enterprise Plus licenses from VMware. Pivot3 is also an Original Equipment Manufacturer (OEM) and Technology Alliance Partner, and is a top tier sponsor of VMware User Group and VMware vForum.
About Pivot3
Founded in 2002, Pivot3 provides patented global hyper-convergence technology that saves an extraordinary amount of space, ensures fault tolerance, drives down complexity and cost and dramatically increases scale-out performance. Today, Pivot3 has more than 1,600 customers around the world deploying more than 13,000 globally hyper-converged infrastructure appliances in multiple industries, such as video surveillance, healthcare, government, transportation, entertainment, education, gaming and retail. The company has won numerous awards and was most recently featured by CRN in their top 50 Virtualization list for 2014. To learn more about Pivot3, visit http://www.pivot3.com .
VMware, vSphere, Horizon, and Mirage are registered trademarks or trademarks of VMware, Inc. in the United States and other jurisdictions. The use of the word “partner” or “partnership” does not imply a legal partnership relationship between VMware and any other company.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151012006212/en/
Contact:
for Pivot3
Allison Francis, 972-235-3439
afrancis@ideagrove.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 17:20:00 CEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 17:00:00 CEST | Press release
Presentations at the 94th European Atherosclerosis Society (EAS) Congress highlight the breadth of evidence for bempedoic acid across a wide range of patient subgroups and background therapies. Real-world data from the MILOS study across multiple European cohorts demonstrate consistent effectiveness and safety profile in routine clinical practice.1,2,3,4 Analysis from the CLEAR Outcomes trial underscores the impact of bempedoic acid on cardiovascular risks, including stroke and venous thromboembolism (VTE).5,6 Daiichi Sankyo Europe’s commitment to "care for every heartbeat" is centred on providing accessible oral treatment options to ensure every patient is given a chance to reach their LDL-C goals. Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom